SARS-CoV-2 BA.2.86 shows increased lung targeting despite va

New research shows that the recently emerged BA.2.86 omicron subvariant of the virus that causes COVID-19 can be neutralized by bivalent mRNA vaccine-induced antibodies in the blood, which explains why this variant did not cause a widespread surge as previously feared.

Related Keywords

Ohio State University , Ohio , United States , Jeffrey Horowitz , Richard Gumina , Eugene Oltz , Shan Lu Liu , Negin Goodarzi , Daniel Jones , Rama Mallampalli , Linda Saif , Joseph Bednash , Kai Xu , Julia Faraone , Claire Carlin , Ohio State College Of Veterinary Medicine , Ohio State Center , Ohio State Comprehensive Cancer Center , Centers For Disease , Ohio State Infectious Diseases Institute , National Center , Robertj Anthony Fund For Cardiovascular Research , Pathogens Program , Department Of Microbial Infection , National Institutes Of Health , World Health Organization , Department Of Veterinary Biosciences , Retrovirus Research , Translational Sciences , Veterinary Biosciences , Ohio State , Microbial Infection , Disease Control , Middle East , Emerging Pathogens Program , Infectious Diseases , National Institutes , Advancing Translational Sciences , Glenn Barber Fellowship , Veterinary Medicine , Cardiovascular Research , Comprehensive Cancer Center , Yi Min Zheng , Sars , Ars Cov 2 , Vaccine , Antibodies , Flood , Fell , Cell Membrane , Coronavirus , Covid 19 , Health Care , Immunity , Embrane , Micron , Pandemic , Protein , Research , Spike Protein , Veterinary , Virology , Virus ,